These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 801249)

  • 21. [Clinical studies with acetyldigoxin. A report of experiences].
    Grüneis P; Hafenbrödl W; Nissel W; Kiss A
    Wien Z Inn Med; 1968; 49(11):436-42. PubMed ID: 4901636
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study on a new cardiac glycoside].
    Zerkowitz A
    Med Welt; 1972 Jan; 23(5):172-3. PubMed ID: 4553028
    [No Abstract]   [Full Text] [Related]  

  • 23. [Editorial: Bioavailability of digoxin].
    Alva Correa JJ
    Medicina (B Aires); 1974; 34(6):669-70. PubMed ID: 4459667
    [No Abstract]   [Full Text] [Related]  

  • 24. [Initial clinical evaluations of a new cardioactive glycoside, beta-methyldigoxin].
    Testoni F; Galante A; Verzelletti L
    Boll Soc Ital Cardiol; 1973; 18(1):45-52. PubMed ID: 4619969
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies of the excretion of digoxin through urine in the human].
    Weiss D; Meyer-Elmen E; Ruiz-Torres A
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():202-5. PubMed ID: 5736264
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-equivalence of digoxin tablets.
    Reissell P; Manninen V; Ojala K; Karjalainen J
    Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bioavailability of Dilanacin and Dilanacin new].
    Sorger D; Gruber G
    Z Gesamte Inn Med; 1982 Dec; 37(24):849-53. PubMed ID: 7170822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological availability of digoxin.
    Shaw TR
    Br Heart J; 1973 May; 35(5):554-5. PubMed ID: 4577277
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of fructose-1,6-diphosphate (FDP) and fructose on the digitalis effect. Therapeutic experiences].
    Tomasi AM; De Lorenzi E; Cattani L; Masoni A
    Clin Ter; 1976 Apr; 77(1):21-51. PubMed ID: 795584
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bioavailability and effect on myocardial function of a solution of digoxin in a soft gelatin capsule].
    Longhini C; Alvisi V; Bagni B; Tralli M; Portaluppi F; Pavani F; Fersini C
    Boll Soc Ital Cardiol; 1976; 21(10):1753-63. PubMed ID: 1031600
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
    Asmussen B; Heinz N
    Arzneimittelforschung; 1980; 30(12):2168-72. PubMed ID: 7194080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lanoxicaps: a new digoxin formulation with improved bioavailability.
    Brown D
    Iowa Med; 1984 Jul; 74(7):303-4. PubMed ID: 6746244
    [No Abstract]   [Full Text] [Related]  

  • 35. Digoxin studies in the elderly.
    Taylor BB; Kennedy RD; Caird FI
    Age Ageing; 1974 May; 3(2):79-84. PubMed ID: 4851392
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 37. [Radioimmunological determination of digitalemia in maintenance therapy. Results, correlations and perspectives for application (author's transl)].
    Testoni F; Caputo V; Coppotelli L; Montemurro G; Tommaselli A
    G Ital Cardiol; 1977; 7(5):494-508. PubMed ID: 873101
    [No Abstract]   [Full Text] [Related]  

  • 38. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 39. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gitoxin--a challenger for digoxin?
    Pellegrin P; Lesne M
    Drug Intell Clin Pharm; 1985 Dec; 19(12):945-6. PubMed ID: 4085356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.